Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133645) titled 'A Study on the Mechanism by Which m6A Modification of circ_104797 Regulates Cisplatin Resistance in Bladder Cancer' on Sept. 30.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Shenzhen Second People's Hospital

Condition: Bladder Cancer (Malignant Tumors of the Bladder)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-30

Target Sample Size: Observation Group for Bladder Cancer Treatment:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=339893

Published by HT Digital Content Services with perm...